The CEO of biotech company Decision Diagnostics Corp., Keith Berman, was sentenced to seven years in prison for a securities fraud scheme that resulted in about $28 million in investor losses and obstruction of a related U.S. Securities and Exchange Commission investigation.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
